The pharmacy chain was accused of filling “millions” of unlawful prescriptions for opioids and other controlled substances. Despite agreeing to the payout, the company does not admit wrongdoing.

AI may finally end the paper chase caused by prior authorization. Or it may worsen it. 

The two companies have been unable to assuage antitrust concerns raised by the Department of Justice. A magistrate will attempt to hammer out acceptable terms for the home healthcare merger at a conference scheduled for August. 

Contrary to popular misgivings, AI may be improving the human touch in healthcare. 

The company said part of its network has been encrypted. However, it told the Securities and Exchange Commission it is still able to deliver dialysis care to patients. 

UnitedHealth Group said it is seeking repayment of “interest-free” advances distributed to providers struggling during the shutdown of claims processing caused by the ransomware attack on Change Healthcare. 

Monoclonal antibody therapies will be the first drugs permitted to take advantage of alternatives, including advanced lab simulations and artificial intelligence. A pilot framework to phase out the decades-long requirement for animal testing will be rolled out in the coming year, the FDA said.

The Department of Health and Human Services is looking to replace lab animals with AI models. Even more bullish on AI is the new boss at the Centers for Medicare and Medicaid Services.